SARAO, Valentina
 Distribuzione geografica
Continente #
NA - Nord America 3.329
EU - Europa 610
AS - Asia 353
AF - Africa 6
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 4.304
Nazione #
US - Stati Uniti d'America 3.310
UA - Ucraina 163
IT - Italia 153
SG - Singapore 151
CN - Cina 116
DE - Germania 77
IE - Irlanda 70
TR - Turchia 45
FI - Finlandia 40
GB - Regno Unito 27
SE - Svezia 22
VN - Vietnam 22
CA - Canada 18
IN - India 14
BE - Belgio 12
PL - Polonia 12
NL - Olanda 11
AT - Austria 6
TG - Togo 5
JP - Giappone 4
AU - Australia 3
CH - Svizzera 3
ES - Italia 2
EU - Europa 2
FR - Francia 2
LU - Lussemburgo 2
RO - Romania 2
BG - Bulgaria 1
BO - Bolivia 1
EG - Egitto 1
GL - Groenlandia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
LT - Lituania 1
ME - Montenegro 1
RU - Federazione Russa 1
Totale 4.304
Città #
Fairfield 428
Woodbridge 377
Chandler 360
Ann Arbor 283
Houston 242
Ashburn 230
Seattle 164
Wilmington 157
Cambridge 132
Singapore 123
Boardman 106
Jacksonville 95
Dearborn 75
Princeton 72
Dublin 70
Beijing 46
Izmir 45
Udine 32
Ogden 25
San Diego 25
Norwalk 23
Dong Ket 22
New York 20
Des Moines 13
Brussels 12
Warsaw 12
Santa Clara 10
Wuhan 10
Falls Church 9
Redmond 8
Shenzhen 8
Bologna 7
Nanjing 7
Ottawa 7
Chengdu 6
Toronto 6
Treviso 6
Vienna 6
Grafing 5
Guangzhou 5
Helsinki 5
Lomé 5
Los Angeles 5
Rome 5
Chioggia 4
Frankfurt am Main 4
Jinan 4
Kunming 4
Lappeenranta 4
Milan 4
Munich 4
Nanchang 4
Tokyo 4
Vicenza 4
Amsterdam 3
Andover 3
Camponogara 3
Edinburgh 3
Hangzhou 3
Hefei 3
Hyderabad 3
Kolkata 3
Montreal 3
Turin 3
Bari 2
Conegliano 2
Latina 2
Latisana 2
Luxembourg 2
Mestre 2
Noida 2
Phoenix 2
Pignone 2
Pomezia 2
Rio Saliceto 2
Schiavon 2
Stockholm 2
Strigno 2
Venezia 2
Washington 2
Wembley 2
Wenzhou 2
Zurich 2
Aiello Del Friuli 1
Arsiero 1
Baotou 1
Brisbane 1
Budapest 1
Buffalo 1
Changsha 1
Chicago 1
Codroipo 1
Cormeilles-en-Parisis 1
Deventer 1
Edmonton 1
Eindhoven 1
Falkenstein 1
Hebei 1
Indiana 1
Jiaxing 1
Totale 3.434
Nome #
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 151
Comparison of short-wavelength blue-light autofluorescence and conventional blue-light autofluorescence in geographic atrophy 135
Fluocinolone acetonide for the treatment of diabetic macular edema 134
A case of CRB1-negative Coats-like retinitis pigmentosa 134
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 129
Proliferative Diabetic Retinopathy: Treatment Update 129
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 120
Neovascular age-related macular degeneration 119
Online optical coherence tomography during subthreshold laser irradiation 118
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 116
Optical coherence tomography angiography findings in diabetic retinopathy 114
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 113
Dexamethasone implant in diabetic macular edema in real-life situations 111
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 109
Update on combination therapy in wet age-related macular degeneration 107
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 105
Drug safety evaluation of intravitreal triamcinolone acetonide 102
Author’s response 101
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 98
Pharmacotherapy for treatment of retinal vein occlusion. 90
Triamcinolone acetonide for the treatment of diabetic macular oedema 86
Safety of 6000 intravitreal dexamethasone implants 85
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 84
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 83
Intravitreal steroids for the treatment of retinal diseases. 79
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 77
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 74
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 72
Green emission fluorophores in eyes with atrophic age-related macular degeneration: A colour fundus autofluorescence pilot study 70
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 69
Regression of diabetic macular edema after subcutaneous exenatide. 68
Steroids in a Combination Strategy 66
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 61
Macular pucker 57
Impact on quality of life 49
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 48
Correction to: Fundamental principles of an effective diabetic retinopathy screening program (Acta Diabetologica, (2020), 57, 7, (785-798), 10.1007/s00592-020-01506-8) 47
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 45
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 43
Edema maculare post occlusione venosa 37
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 37
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 36
Choroidal Thickness Influences Green Emission Autofluorescence Component Intensity in Eyes with Geographic Atrophy Due to Age-Related Macular degeneration: A Color Fundus Autofluorescence Study 35
Does lens influence green component in short 450 nm color autofluorescence? A cross-sectional study in heathy Caucasian population 35
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 34
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 34
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 33
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 33
Screening performance of an automated image analysis software for the detection of diabetic retinopathy using a conventional fundus photography or a confocal white LED device: a comparison study 32
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 32
Present Status of Laser Therapy: Role of Subthreshold Laser 31
Ranibizumab in neovascular age-related macular degeneration: an as-needed treatment regimen with bimonthly evaluation 29
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 28
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 28
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 28
OCT angiography in chronic central serous chorioretinopathy 27
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 27
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 26
Long-term Effect of Intravitreal Bevacizumab on Chorioretinal Atrophy Progression in Myopic Choroidal Neovascularization 26
Stem cell therapy in retinal diseases: current evidence 23
The Present and Future of Optic Pathway Glioma Therapy 21
Vitrectomized vs non-vitrectomized eyes in DEX implant treatment for DMO—Is there any difference? the VITDEX study 20
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 19
Macular Holes 17
Twelve-month treatment with intravitreal dexamethasone implant for diabetic macular edema 17
Response to:Letter to the editor: Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 17
One-year outcomes of dexamethasone implant versus oral acetazolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa 16
Fundamental principles of an effective diabetic retinopathy screening program 15
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 15
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 14
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 14
Surgical Management for Diabetic Macular Edema 13
State-of-the art pharmacotherapy for non-neovascular age-related macular degeneration 13
Long-term outcomes after intravitreal dexamethasone treatment in steroid responders 13
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 12
Biosimilar ranibizumab (BS1) – early experience from Japan (BRIJ study) 11
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 11
Response to: New norms in ophthalmic surgery during the COVID-19 pandemic: A narrative review from a Malaysia tertiary eye care center 11
Response to: Should we establish a new normality for ophthalmic training in the COVID-19 pandemic? 11
Lens fogging comment on “Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy” 11
Anti-VEGF Biosimilars for Retinal Diseases Survey 2023- India (Bio-INDAS) by the International Retina Biosimilar Study Group (Inter-BIOS Group) in collaboration with the Vitreo-Retinal Society of India (VRSI) 9
The ideal intravitreal injection setting: office, ambulatory surgery room or operating theatre? A narrative review and international survey 7
Totale 4.556
Categoria #
all - tutte 20.568
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.568


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020805 0 0 0 0 85 162 102 122 97 79 28 130
2020/2021675 33 70 68 98 36 56 28 70 84 27 52 53
2021/2022451 22 26 9 7 14 22 35 23 18 84 101 90
2022/2023758 96 51 7 121 82 179 0 71 97 4 31 19
2023/2024261 46 17 7 6 35 30 11 26 37 15 2 29
2024/2025327 27 97 100 76 27 0 0 0 0 0 0 0
Totale 4.556